Ocuphire Pharma Inc. Stock
Ocuphire Pharma Inc. Stock
Ocuphire Pharma Inc. dominated the market today, gaining €0.078 (5.170%).
Currently there is a rather positive sentiment for Ocuphire Pharma Inc. with 5 Buy predictions and 1 Sell predictions.
With a target price of 18 € there is potential for a 1062.79% increase which would mean more than doubling the current price of 1.55 € for Ocuphire Pharma Inc..
Our community identified positive and negative aspects for Ocuphire Pharma Inc. stock for the coming years. 2 users see the criterium "Worthwhile Investment for the next years" as a plus for the Ocuphire Pharma Inc. stock. On the other hand our users think that "Innovation" could be a problem in the future.
Pros and Cons of Ocuphire Pharma Inc. in the next few years
Pros
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
B****
Cons
?
S********** s********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Ocuphire Pharma Inc. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Ocuphire Pharma Inc. | 5.170% | 9.477% | -16.685% | -67.029% | -44.615% | - | - |
Immunic Inc. | 5.600% | 1.892% | -3.580% | -21.627% | -17.133% | -90.735% | - |
NanoViricides Inc. | 1.980% | 0.980% | -0.962% | -8.850% | 8.995% | -69.812% | -75.787% |
AnaptysBio Inc | 2.050% | 9.945% | -4.327% | 5.851% | 2.577% | 3.646% | - |
Comments
Ocuphire Pharma, Inc. (NASDAQ: OCUP) had its price target lowered by analysts at Alliance Global Partners from $24.00 to $20.00. They now have a "buy" rating on the stock.
Show more
Ratings data for OCUP provided by MarketBeat
Ocuphire Pharma, Inc. (NASDAQ: OCUP) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $20.00 price target on the stock.
Show more
Ratings data for OCUP provided by MarketBeat
Ocuphire Pharma, Inc. (NASDAQ: OCUP) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $17.00 price target on the stock.
Show more
Ratings data for OCUP provided by MarketBeat